114 related articles for article (PubMed ID: 7517378)
41. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
Funkhouser A; Clements ML; Slome S; Clayman B; Viscidi R
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):627-32. PubMed ID: 8369168
[TBL] [Abstract][Full Text] [Related]
42. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
[TBL] [Abstract][Full Text] [Related]
43. Quantitative and qualitative changes in intestinal immunoglobulin-bearing plasma cells in jejunal mucosa of 52 HIV-infected patients.
Trajman A; Belo M; Oliveira A; Madi K; Elia C
Braz J Med Biol Res; 1994 May; 27(5):1215-24. PubMed ID: 8000343
[TBL] [Abstract][Full Text] [Related]
44. IgA1, IgA2 or secretory piece containing antigliadin antibodies in the sera of coeliac patients.
Blanco A; Arranz E; Alonso M; Sánchez Villares E
Allergol Immunopathol (Madr); 1989; 17(2):77-80. PubMed ID: 2773754
[TBL] [Abstract][Full Text] [Related]
45. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.
Hocini H; Bélec L; Iscaki S; Garin B; Pillot J; Becquart P; Bomsel M
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1179-85. PubMed ID: 9310284
[TBL] [Abstract][Full Text] [Related]
46. IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis.
Sandin C; Eriksson P; Segelmark M; Skogh T; Kastbom A
Clin Exp Immunol; 2016 May; 184(2):208-15. PubMed ID: 26762653
[TBL] [Abstract][Full Text] [Related]
47. Serum secretory IgA, IgA1 and IgA2 subclasses in inflammatory bowel and chronic liver diseases.
Soppi E; Granfors K; Leino R
J Clin Lab Immunol; 1987 May; 23(1):15-7. PubMed ID: 3612757
[TBL] [Abstract][Full Text] [Related]
48. Immunoglobulin isotype profile of tissue transglutaminase autoantibodies is correlated with the clinical presentation of coeliac disease.
Schilling J; Spiekerkoetter U; Wohlrab U; Wendel U; Seissler J
Scand J Immunol; 2005 Feb; 61(2):207-12. PubMed ID: 15683458
[TBL] [Abstract][Full Text] [Related]
49. Secretory immunity in HIV infection.
Schneider T; Zippel T; Schmidt W; Zeitz M; Ullrich R
Pathobiology; 1998; 66(3-4):131-8. PubMed ID: 9693313
[TBL] [Abstract][Full Text] [Related]
50. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.
Michaëlsson G; Kraaz W; Gerdén B; Hagforsen E; Lundin IP; Lööf L; Sj-oberg O; Scheynius A
Br J Dermatol; 1996 Sep; 135(3):371-8. PubMed ID: 8949428
[TBL] [Abstract][Full Text] [Related]
51. A pathogenic role for secretory IgA in IgA nephropathy.
Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264
[TBL] [Abstract][Full Text] [Related]
52. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
53. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
[TBL] [Abstract][Full Text] [Related]
54. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity.
Garcia-Nieto RM; Rico-Mata R; Arias-Negrete S; Avila EE
Parasitol Int; 2008 Dec; 57(4):417-23. PubMed ID: 18571975
[TBL] [Abstract][Full Text] [Related]
55. Increased IgA antibodies to gluten and gliadin in serum of persons with ocular pseudo-exfoliation.
Ringvold A; Overgaard RG
Acta Ophthalmol Scand; 1995 Apr; 73(2):171-2. PubMed ID: 7656149
[TBL] [Abstract][Full Text] [Related]
56. Effects of IL6 on B cells in mucosal immune response and inflammation.
Fujihashi K; Kono Y; Kiyono H
Res Immunol; 1992 Sep; 143(7):744-9. PubMed ID: 1439148
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin secreting cells in lymphocytes of patients with IgA deficiency or hyper-IgA.
Kondo N; Takao A; Li GP; Kuwabara N; Fujii H; Orii T
Biotherapy; 1993; 6(4):279-82. PubMed ID: 8018448
[TBL] [Abstract][Full Text] [Related]
58. Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal overgrowth with indigenous gut flora.
Riordan SM; McIver CJ; Wakefield D; Thomas MC; Duncombe VM; Bolin TD
Dig Dis Sci; 1999 May; 44(5):939-44. PubMed ID: 10235601
[TBL] [Abstract][Full Text] [Related]
59. Serum IgA antibodies to human gut luminal aspirates and human liver in alcoholic liver disease.
Douds AC; Lewis DJ; Lim AG; Maxwell JD; Poulton TA
Alcohol Clin Exp Res; 1998 Oct; 22(7):1383-8. PubMed ID: 9802516
[TBL] [Abstract][Full Text] [Related]
60. [Spondylarthropathies and the IgA system].
Wendling D
Rev Med Interne; 1994 Jan; 15(1):55-61. PubMed ID: 8052756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
